Microtubule-interacting drugs for cancer treatment

Author： Checchi P.M.   Nettles J.H.   Zhou J.   Snyder J.P.   Joshi H.C.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.24, Iss.7, 2003-07, pp. : 361-365

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Microtubule-targeting drugs and personalization of cancer treatment

By Rodrííguez-Antona Cristina   Grééen Henrik  

Pharmacogenomics, Vol. 12, Iss. 4, 2011-04 ,pp. : 449-451

Future Medicine

Access to resources Recommend Favorite

Looking at Drug Resistance Mechanisms for Microtubule Interacting Drugs: Does TUBB3 Work?

By  

Current Cancer Drug Targets, Vol. 7, Iss. 8, 2007-12 ,pp. : 704-712

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging drugs for the treatment of pancreatic cancer

By Van Laethem Jean-Luc   Marechal Raphael  

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 2, 2007-05 ,pp. : 301-311

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs in the treatment of pancreatic cancer

By Mahalingam Devalingam   Kelly Kevin R   Swords Ronan T   Carew Jennifer   Nawrocki Steffan T   Giles Francis J  

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 2, 2009-06 ,pp. : 311-328

Informa Healthcare

Access to resources Recommend Favorite

Thalidomide and immunomodulatory drugs in the treatment of cancer

By Bamias Aristotle   Dimopoulos Meletios A  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 1, 2005-01 ,pp. : 45-55

Informa Healthcare

Access to resources Recommend Favorite